Core Viewpoint - The actual controller of Beiliangong, Ma Xuejun, is under investigation by the China Securities Regulatory Commission (CSRC) for suspected market manipulation, marking the second investigation within a month [2][5]. Group 1: Company Background - Beiliangong was established in 2001 and went public on the Sci-Tech Innovation Board in July 2021, focusing on the design, research, development, production, sales, and service of smart portable health hardware, including products like neck and eye massagers [2]. - Ma Xuejun has been leading the company since its inception and currently holds a direct shareholding of 37.51%, controlling a total of 49.38% of the company's shares [2]. Group 2: Regulatory Issues - Ma Xuejun has previously faced regulatory inquiries due to fund occupation issues, including the misappropriation of 16.69 million yuan through employee loans and transferring 54 million yuan via related enterprises [3]. - In 2024 alone, the total amount of funds occupied reached 85.93 million yuan, with some amounts still unpaid by the end of the period [4]. Group 3: Financial Performance - Beiliangong reported a revenue of 1.085 billion yuan and a net profit of only 10.25 million yuan in its 2024 annual report, while the 2025 Q3 report indicated total assets of 676 million yuan and liabilities of 398 million yuan, leaving shareholders' equity at 278 million yuan [4]. - The company has faced continuous losses, with a projected net profit loss of 84 million to 105 million yuan for the entire year of 2025, and has received performance inquiry letters from the Shanghai Stock Exchange for four consecutive years, highlighting ongoing issues with information disclosure compliance [4].

Core Viewpoint - The company Beike (688793.SH) is under investigation by the China Securities Regulatory Commission (CSRC) for market manipulation, involving its actual controller and chairman, Ma Xuejun, who has been investigated twice in a short period for various financial misconducts [1][2]. Group 1: Company Background - Beike was established in 2001 and went public on the Sci-Tech Innovation Board in July 2021, focusing on the design, research, development, production, sales, and service of smart portable health hardware, including products like neck and eye massagers [1]. - Ma Xuejun has been the main operator since the company's inception, holding a direct stake of 37.51% and controlling a total of 49.38% of the shares, giving him absolute control over the company [1]. Group 2: Financial Misconduct - Ma Xuejun has been involved in various financial misconducts, including the misappropriation of company funds totaling 16.69 million yuan through employee loans, transferring 54 million yuan via related companies, and prepaying suppliers, with a total of 85.93 million yuan misappropriated in 2024 alone [2]. - The company has also failed to disclose 30 million yuan in illegal guarantees, raising further concerns about its governance [2]. Group 3: Financial Performance - In 2024, Beike reported revenues of 1.085 billion yuan and a net profit of only 10.25 million yuan. By the third quarter of 2025, the company's total assets were 676 million yuan, liabilities were 398 million yuan, and shareholders' equity was reduced to 278 million yuan, with a negative cash flow from operating activities of 28.1 million yuan [3]. - As of February 6, 2026, the company's stock price was 22.71 yuan per share, reflecting a decline of approximately 81.5% from its peak market value, with a total market capitalization of 1.952 billion yuan [3]. Group 4: Regulatory Response - The company stated that the investigation pertains to Ma Xuejun personally and is not expected to significantly impact its daily operations, with Ma continuing to fulfill his duties and the company pledging to cooperate with the regulatory investigation [3].

Core Viewpoint - The A-share market experienced a general decline this week, with the Sci-Tech 50 index falling by 5.8%, while the Northern Securities 50 index saw a smaller decline of 0.7%. The overall performance of the Sci-Tech sector indices was below the weighted median [1][4]. Group 1: Major Events in the Sci-Tech Board - One IPO occurred this week: Shenzhen Beixin Life Technology Co., raising 999 million [11]. - There were 13 new merger and acquisition developments, including the acquisition of 100% equity of Jingyi Integration by Jinghe Integration and the planned capital increase acquisition of Lingming Photon by Zhiyang Innovation [11][35]. - The chairman of Beiqi Technology (688793) received a notice from the CSRC regarding a market manipulation investigation, marking the second time in two months [26]. Group 2: Industry Performance - The internal performance of the Sci-Tech board showed divergence, with the chip design and AI sectors at the bottom, while the new energy sector was one of the few with positive returns [2][28]. - The top ten weight companies on the Sci-Tech board showed mixed results, with Cambrian (688256) dropping by 17.6%, while Zhongwei Company was the only one with positive returns [30]. Group 3: Stock Performance - The top gainers this week included: - Olay New Materials (688530) with a gain of 32.25% - JinkoSolar (688223) with a gain of 31.60% - Hexin Instruments (688622) with a gain of 30.46% [32]. - The top losers included: - Aerospace Hongtu (688066) with a loss of 33.82% - Kaipu Cloud (688228) with a loss of 32.80% - Jucheng Shares (688123) with a loss of 20.26% [33]. Group 4: Trading Volume - The top ten companies by trading volume included: - Cambrian (688256) with a trading volume of 633 million - Lanke Technology (688008) with a trading volume of 464 million - Zhongwei Company (688981) with a trading volume of 272 million [33]. Group 5: Recent Unlocking of Shares - Recent unlocking of shares includes: - Mylan (688273) with an unlocking amount of 2.7 billion on February 11 - Longxun Shares (688486) with an unlocking amount of 4.3 billion on February 24 - Haohan Depth (688292) with an unlocking amount of 1.6 billion on February 24 [34]. Group 6: Fund Analysis - There are over 40 public funds related to the Sci-Tech board, with a total scale exceeding 140 billion, primarily categorized into three types: tracking the Sci-Tech 50 index, tracking the Double Innovation 50 index, and tracking the Sci-Tech board's sub-industry indices [37]. - The largest funds by scale include: - Sci-Tech 50 ETF (588000) with a scale of 76 billion - Sci-Tech Board 50 ETF (588080) with a scale of 70.6 billion [37].

Key Points - The company Beike (688793) closed at 22.71 yuan on February 6, 2026, down 1.13% with a turnover rate of 2.09% and a trading volume of 18,000 hands, resulting in a transaction amount of 40.79 million yuan [1] - On February 6, the main funds experienced a net outflow of 4.36 million yuan, while retail investors saw a net inflow of 3.51 million yuan [2] - The chairman, Ma Xuejun, is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of securities laws, specifically market manipulation [1][2] - The investigation pertains to Ma Xuejun personally and does not affect the company's normal operations, with the company stating that all business activities are proceeding as usual [1][2]

Core Viewpoint - The regulatory scrutiny on listed companies in China's A-share market has intensified, with multiple companies facing investigations and penalties for violations related to information disclosure and financial misconduct [2][10]. Group 1: Recent Investigations and Penalties - Two A-share companies, Tian Sheng New Materials and Yahui Long, were recently announced to be under investigation for suspected information disclosure violations [2][6]. - ST Funi was fined 6.5 million yuan for financial fraud involving collusion with a third-party company, which led to inflated profits of approximately 35.8 million yuan in 2020 [3][4]. - Rongbai Technology was fined 9.5 million yuan for misleading statements regarding a major contract, with the investigation concluding within a month [5][6]. Group 2: Overview of Violations - A total of eight A-share companies and four individuals have been investigated since the beginning of 2026, with the majority facing issues related to information disclosure violations [6][7]. - Specific cases include Baoxin Technology and its actual controller being investigated for information disclosure violations, and the independent director of *ST Dongjing being investigated for insider trading [7][8]. Group 3: Regulatory Environment - The regulatory environment has become increasingly stringent, with a significant number of companies being penalized for financial misconduct in 2025, particularly in the area of information disclosure violations [10][12]. - The China Securities Regulatory Commission (CSRC) has emphasized the need for a comprehensive system to combat financial fraud, indicating a shift towards proactive governance rather than reactive measures [12][13].

Core Viewpoint - The regulatory scrutiny on A-share companies has intensified, with multiple companies being investigated and penalized for violations related to information disclosure and financial misconduct since 2026 [1][15]. Group 1: Recent Investigations and Penalties - Eight A-share companies and four related individuals have been investigated since 2026, with recent cases including Tian Sheng New Materials and Aihui Long, both facing allegations of information disclosure violations [1][9]. - ST Fuhua was fined 6.5 million yuan for financial fraud involving collusion with a third-party company, which led to inflated profits of approximately 35.8 million yuan in 2020 [3][4]. - Rongbai Technology was fined a total of 9.5 million yuan for misleading statements regarding a major contract with Ningde Times, which was deemed to lack accurate reflection of the actual terms [6][7]. Group 2: Specific Cases and Financial Impact - ST Fuhua's financial misconduct resulted in a reported revenue of 740 million yuan in 2020, a year-on-year increase of 169.36%, but the company still recorded a net loss when excluding the inflated profits [5][4]. - The inflated profits from ST Fuhua's subsidiary accounted for 120.18% of the total profit disclosed for that period, indicating severe discrepancies in financial reporting [4]. - The investigation into Rongbai Technology revealed that the announced sales figures were based on estimates and lacked contractual guarantees, leading to regulatory action [6][8]. Group 3: Broader Regulatory Trends - The regulatory environment has become increasingly stringent, with a notable increase in investigations into financial misconduct and information disclosure violations among A-share companies [15][19]. - In 2025, a total of 87 A-share companies were investigated, with over 40% being ST companies, highlighting a trend of heightened scrutiny in the market [16]. - The China Securities Regulatory Commission (CSRC) has emphasized a comprehensive approach to tackling financial fraud, involving collaboration with judicial authorities to enhance enforcement and accountability [18][19].

登录新浪财经APP 搜索【信披】查看更多考评等级 新京报贝壳财经记者 阎侠 编辑 岳彩周 校对 赵琳 两个月不到，2月4日又一份《立案告知书》摆在了倍轻松实控人马学军的面前。 从涉嫌信披违规到涉嫌操纵市场，监管目光持续聚焦的背后，还有实控人此前资金占用往事。 2月6日，倍轻松的股价开盘即下跌，截至收盘，其股价为22.71元/股，跌幅为1.13%，公司总市值约 19.52亿元。自2021年上市即巅峰后，这家公司的市值已较高峰时跌去超80%。 此前，公司发布了一份2025年归母净利润盈转亏的业绩预告，预亏金额亿元左右。记者注意到倍轻松业 绩波动较大，2021年和2024年盈利，2022年和2023年亏损，2025年预亏。而其扣非净利润已连续四年亏 损。 从涉嫌信披违规到涉嫌操纵市场 倍轻松实控人马学军两个月内收到两份立案告知书 2月5日晚间，倍轻松发布公告称，公司于2026年2月4日收到中国证监会对实际控制人马学军下发的《立 案告知书》，因其涉嫌操纵证券市场，根据相关法律法规，中国证监会决定对其立案。 值得一提的是，这已经是马学军在两个月内被下发的第二份《立案告知书》。2025年12月25日，倍轻松 收到中国证监 ...

据经济观察报-经济观察网 2月5日，深圳市倍轻松（维权）科技股份有限公司发布公告称，公司实际控 制人马学军于2月4日收到中国证监会下发的《立案告知书》（编号：证监立案字0382026021号），因其 涉嫌操纵证券市场，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国 证监会决定对其立案。这是马学军在2025年12月因涉嫌信息披露违法违规被立案后，短期内第二次接受 证监会调查。 登录新浪财经APP 搜索【信披】查看更多考评等级 ...

2000年，倍轻松品牌正式创立，并推出首款眼部按摩器产品。2021年7月，倍轻松以"智能按摩设备 第一股"身份登陆科创板，上市首日开盘报160元/股，较发行价27.4元/股上涨484%，市值一度突破百亿 元。 然而，上市即成为公司股价高点，此后倍轻松股价步入长期下行通道，市值持续萎缩。目前约20亿 元的市值，较巅峰时期已蒸发超过80%。 值得关注的是，在前次被立案调查约一个月前，马学军刚刚完成一笔大规模减持。2025年11月21 日，倍轻松公告显示，马学军通过询价转让方式减持公司股份255.26万股，占总股本的2.97%，转让价 格25.35元/股，套现约6471万元。减持后，马学军及其一致行动人持股比例由52.35%降至49.38%。 减持背后，是倍轻松持续承压的业绩表现。财务数据显示，2021年上市当年，公司营收达11.9亿 元，归母净利润0.92亿元，创下业绩高峰，此后便进入下行期。自2022年起，公司归母净利润持续亏 损，尽管2024年短暂扭亏，2025年前三季度却又陷入营收与利润双双下滑的局面。 "智能按摩设备第一股"倍轻松实际控制人、董事长马学军再遭监管立案。 2月5日晚，倍轻松发布公告称，实际控 ...

Core Viewpoint - The actual controller of Shenzhen Beiliang Technology Co., Ltd., Ma Xuejun, is under investigation by the China Securities Regulatory Commission (CSRC) for suspected market manipulation, following a previous investigation for information disclosure violations, raising concerns about the company's governance and financial stability [2][3]. Group 1: Company Performance and Financial Outlook - Beiliang announced a significant expected loss for the fiscal year 2025, projecting a net profit attributable to shareholders of between -105 million and -84 million yuan, contrasting sharply with a profit of 10.25 million yuan in the same period last year [2][3]. - The company attributes this drastic change in performance to a transitional period in its business strategy, leading to revenue decline and unmet expectations regarding sales expenses, alongside fixed costs not being reduced accordingly [3]. Group 2: Governance and Regulatory Issues - The focus has shifted from individual events to a systemic risk assessment of the company's governance structure, as Ma Xuejun holds multiple key positions (Chairman and General Manager), leading to concerns about decision-making transparency and internal control failures [3]. - The CSRC's investigations have progressed from issues of information disclosure compliance to potential personal misconduct affecting market fairness, indicating a deeper scrutiny of Ma Xuejun's actions [3][4]. Group 3: Market Reactions and Investor Sentiment - Following Ma Xuejun's share reduction of approximately 6.47 million yuan shortly before the investigations, there are strong market suspicions regarding the timing and implications of this transaction, particularly whether it involved undisclosed information [5]. - The company is also facing a patent infringement lawsuit with a claim of 10 million yuan, adding to the negative perception and compounded crisis image, which challenges the management's ability to maintain investor confidence [6].